Abcellera Biologics Inc (ABCL) — Cash Flow Reinvestment Rate
Abcellera Biologics Inc (ABCL) has a Cash Flow Reinvestment Rate of 1.89x as of June 2023, reinvesting $37.52 Million (capex $27.35 Million plus investments $-10.17 Million) from operating cash flow of $19.82 Million. Check ABCL cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Abcellera Biologics Inc Cash Flow Reinvestment Rate (2018–2022)
Historical reinvestment intensity for Abcellera Biologics Inc across 5 annual periods. Explore long-term investment intensity of Abcellera Biologics Inc to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Abcellera Biologics Inc (2018–2022)
Year-by-year capital reinvestment analysis for Abcellera Biologics Inc. For live market cap and broader valuation context, see how much is Abcellera Biologics Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.53x | $425.29 Million | $277.36 Million | $72.66 Million | ▲ +11.7% |
| 2021 | 1.37x | $335.88 Million | $244.58 Million | $58.45 Million | ▼ -8.1% |
| 2020 | 1.49x | $33.92 Million | $22.69 Million | $14.67 Million | ▼ -58.8% |
| 2019 | 3.63x | $9.78 Million | $2.69 Million | $4.00 Million | ▲ +21.9% |
| 2018 | 2.98x | $10.61 Million | $3.56 Million | $5.31 Million | — |